Enline Announces Commercial Partnership with Microsoft

MicrosoftEnline plc, one of the UK's leading Identity and Access Management (IAM) solution providers, has announced it has become a Microsoft partner in the UK to deliver and sell Microsoft's health-specific IAM products. Enline has extensive knowledge of the health market and a clear vision of the benefits provided by solutions such as clinical context and user provisioning to NHS organisations.

The NHS is facing an incredible challenge to provide an ever increasing level of service while having to deal with continuing pressures on available budgets. Healthcare organisations are expected to operate more efficiently and improve the effectiveness of existing clinical systems whilst undergoing a period of transition. Providing Clinicians with the right patient data, appropriate to their role and in a format best suited to their requirements is core to the effort required to create these efficiencies.

In the UK, Microsoft's IAM portfolio consists of three products created specifically for healthcare organisations: expreSSO, a next-generation cost efficient single sign-on solution, Vergence, which unifies the single sign-on capability of expreSSO with context management, role-based access and strong authentication into a fully integrated clinical workstation and Microsoft proVision for automated centralised creation and management of network and application accounts. Collectively over 17 NHS trusts have signed contracts for IAM products from Microsoft to help deliver better clinical efficiency and reduced costs.

Whether used separately or collectively, the products enable the right people to access the right information at the right time. Microsoft has in the past year seen rapid enterprise-wide deployment with 17 NHS Trusts now using one or more Microsoft IAM products.

The addition of Enline represents an expansion in Microsoft's commercial strategy to adopt a channel approach that complements its existing direct to NHS approach.

John Gobron, Director Health Solutions Microsoft said: "We are pleased that Enline, as an IAM specialist with a wealth of experience in healthcare, has chosen to partner with Microsoft at such a critical time for the NHS. Healthcare organisations need to focus on vital issues of efficiency in infrastructure, people and outcomes and Enline will be delivering our innovative IAM products to help Trusts provide their clinicians with streamlined access to applications and patient data."

Mike Nelsey, Managing Director Enline plc said: "We are delighted to launch our association with Microsoft. Using solutions from Microsoft such as Clinical Context management and User Provisioning along with our wealth of experience, we can help Trusts to deliver a user-orientated approach to the challenge of multiple application logon, patient privacy and information delivery where and when it is needed."

Related news articles:

About Microsoft in Health
Microsoft is committed to improving health around the world through software innovation. Over the past 13 years, Microsoft has steadily increased its investments in health with a focus on addressing the challenges of health providers, health and social services organisations, payers, consumers and life sciences companies worldwide. Microsoft closely collaborates with a broad ecosystem of partners and delivers its own powerful health solutions, such as Amalga, HealthVault, and a portfolio of identity and access management technologies acquired from Sentillion Inc. in 2010. Together, Microsoft and its industry partners are working to deliver health solutions for the way people aspire to work and live.

About Microsoft
Founded in 1975, Microsoft (Nasdaq "MSFT") is the worldwide leader in software, services and solutions that help people and businesses realise their full potential.

Most Popular Now

AI in Personalized Cancer Medicine: New …

The application of AI in precision oncology has so far been largely confined to the development of new drugs and had only limited impact on the personalisation of therapies. New...

AI can Predict Brain Cancer Patients…

Artificial Intelligence (AI) can predict whether adult patients with brain cancer will survive more than eight months after receiving radiotherapy treatment. The use of the AI to successfully predict patient outcomes...

Max Planck Institute for Informatics and…

The Max Planck Institute for Informatics and Google deepen their strategic research partnership. With additional financial support from the U.S. IT company, the "Saarbr├╝cken Research Center for Visual Computing, Interaction...

JMIR Medical Informatics Invites Submiss…

JMIR Publications has announced a new section titled, "AI Language Models in Health Care" in JMIR Medical Informatics. This leading peer-reviewed journal is indexed in PubMed and has a unique...

Paper Calls for Patient-First Regulation…

Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the morning paper is going to save your life? A new study published in JAMA...

Could ChatGPT Help or Hurt Scientific Re…

Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short...

Evaluating the Performance of AI-Based L…

A new study evaluates an artificial intelligence (AI)-based algorithm for autocontouring prior to radiotherapy in head and neck cancer. Manual contouring to pinpoint the area of treatment requires significant time...

Making AI a Partner in Neuroscientific D…

The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence...

Chapman Scientists Code ChatGPT to Desig…

Generative artificial intelligence platforms, from ChatGPT to Midjourney, grabbed headlines in 2023. But GenAI can do more than create collaged images and help write emails - it can also design...

DMEA nova Award: Wanted - Visionary Solu…

9 - 11 April 2024, Berlin, Germany. The DMEA nova Award is being presented at DMEA 2024 for the first time. The award honours a digital health startup for an outstanding...

New Digital Therapy Reduces Anxiety and …

A therapist-guided digital cognitive behavioural therapy reduced distress in 89 per cent of participants living with long-term physical health conditions, a new King's College London study finds. Researchers at the Institute...

Europe's Digital Health Industry Me…

9 - 11 April 2024, Berlin, Germany. In just over two months, from 9 to 11 April 2024, DMEA, Europe's leading event for digitalisation of healthcare, will gather digital health experts...